SN-008(Cat No.:I045192)is a potent, selective inhibitor of the NLRP3 inflammasome, a key regulator of innate immunity that controls activation of caspase-1 and maturation of IL-1β and IL-18. By blocking NLRP3 activation, SN-008 suppresses excessive inflammation and pyroptosis, offering therapeutic potential for autoimmune, metabolic, and neurodegenerative diseases. It has shown strong activity in preclinical models of gout, type 2 diabetes, atherosclerosis, and Alzheimer’s disease. SN-008 is a valuable research tool for elucidating inflammasome signaling and developing targeted anti-inflammatory strategies aimed at NLRP3-driven pathological conditions while maintaining normal immune defense.